June 27, 2024 — Radical Imaging, a trailblazer in medical imaging viewer solutions, proudly announces that 

June 27, 2024 — Clarius Mobile Health, which provides high-definition handheld ultrasound systems, has obtained U.S. Food and Drug Administration (FDA) clearance for the Clarius OB AI fetal biometric measurement tool, improving access to obstetrical (OB) prenatal monitoring and care in resource-limited areas.

The Society of Cardiovascular Computed Tomography (SCCT) 19th annual scientific meeting, SCCT24, will be held July 18-21, in Washington, DC.

June 27, 2024 — The countdown has begun for the Society of Cardiovascular Computed Tomography (SCCT) 19th Annual Scientific Meeting, SCCT24, “At the heart of it,” to be held July 18-21, in Washington, DC. Planners have designed this year’s program and events to engage physicians, trainees, technologists and healthcare professionals in a complete overview of the cardiovascular CT field.

June 27, 2024 — Prenuvo, which makes whole-body MRI screening for early cancer detection and other diseases, has announced the launch of its first clinical research study at the Hercules Research Center outside Boston, MA.

June 27, 2024 — Thirona, a Netherlands-based global company providing high-precision advanced lung image analysis with artificial intelligence (AI), has announced multiple partnerships recently, following its receipt of U.S. Food and Drug Administration (FDA) approval for its latest update of its AI-based clinical software LungQ (v3.0.0).

June 26, 2024 — Apollo, a leading provider of multidisciplinary medical imaging solutions, will unveil the new version of its flagship multi-disciplinary medical imaging platform, arcc, at the 2024 SIIM Annual Meeting + InformaticsTECH Expo to be held in National Harbor, Maryland, from June 27-29.

June 26, 2024 — Visage Imaging, Inc., a wholly owned subsidiary of Pro Medicus Ltd., has announced it will showcase new product enhancements and innovations for the industry-leading Visage 7 Enterprise Imaging Platform (“Visage 7”) at the Society for Imaging Informatics in Medicine (SIIM) 2024 annual meeting, Booth 503/505/507, Gaylord National Harbor (National Harbor, MD) from Thursday, June 27 – Saturday, June 29, 2024.

June 26, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced it will highlight new research demonstrating the efficacy of its ProFound AI Risk algorithm in breast cancer risk assessment compared to traditional models at the upcoming Society for Imaging Informatics in Medicine (SIIM) Annual Meeting.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now